Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGSWW) Intangibles (2022 - 2025)

GeneDx Holdings has reported Intangibles over the past 4 years, most recently at $168.5 million for Q4 2025.

  • Quarterly results put Intangibles at $168.5 million for Q4 2025, up 6.23% from a year ago — trailing twelve months through Dec 2025 was $168.5 million (up 6.23% YoY), and the annual figure for FY2025 was $168.5 million, up 6.23%.
  • Intangibles for Q4 2025 was $168.5 million at GeneDx Holdings, down from $172.6 million in the prior quarter.
  • Over the last five years, Intangibles for WGSWW hit a ceiling of $193.7 million in Q2 2022 and a floor of $155.1 million in Q1 2025.
  • Median Intangibles over the past 4 years was $172.6 million (2023), compared with a mean of $174.0 million.
  • Peak annual rise in Intangibles hit 6.69% in 2025, while the deepest fall reached 8.29% in 2025.
  • GeneDx Holdings' Intangibles stood at $186.6 million in 2022, then fell by 7.51% to $172.6 million in 2023, then decreased by 8.12% to $158.6 million in 2024, then rose by 6.23% to $168.5 million in 2025.
  • The last three reported values for Intangibles were $168.5 million (Q4 2025), $172.6 million (Q3 2025), and $176.7 million (Q2 2025) per Business Quant data.